Zhongchao Inc.

ZCMD • Medical - Healthcare Information Services

$0.85

▼ -0.03 (-3.77%)

Current price

EarningsLatest report: Dec 31, 2025

HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.

Market Cap

$2.95M

Growth

-24.4%

Cash Flow

2/5

Trend

Volatile

Evidence

Positive free cash flow · 0.2Manageable debt level · 0Healthy liquidity · 11.11Negative growth trendWeak profitability

Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Apr 24, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.85

Change-3.77%

Shares Out3.47M

Market Cap$2.95M

Enterprise Value$-10.95M

Beta-0.07

P/E-0.42

P/S0.11

P/B0.16

P/FCF-0.77

EV/Sales-0.40

EV/EBITDA1.89

Price$0.85

Change-3.77%

Shares Out3.47M

Market Cap$2.95M

Enterprise Value$-10.95M

Beta-0.07

P/E-0.42

P/S0.11

P/B0.16

P/FCF-0.77

EV/Sales-0.40

EV/EBITDA1.89

EV/FCF2.86

Earnings Yield-235.76%

FCF Yield-129.71%

Dividend Yield0.00%

Gross Margin42.47%

Oper. Margin-54.43%

Profit Margin-55.47%

Debt/Eq0.00

Current Ratio11.11

Quick Ratio11.11

Revenue 5Y-24.45%

Volume639.99K

Avg Volume726.71K

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

22/100

Financial Strength

Debt, cash, stability

76/100

Growth Potential

Revenue and expansion

20/100

Price Attractiveness

Cheap or expensive today

89/100

Why this score▼

Positive free cash flow · 0.2Manageable debt level · 0Healthy liquidity · 11.11Negative growth trendWeak profitability

Analyst view

No analyst data available now.

Company Overview

IPO: 2/24/2020

Industry: Medical - Healthcare Information Services

P/B i: 0.16

Debt / Equity i: 0.00

Operating Margin: -54.43%

Net Margin: -55.47%

ROE i: -

ROIC: -

Financial Health

Score15 / 20

Debt / Equity: 0.00

Current Ratio: 11.11

Quick Ratio: 11.11

Status: Good

Insider Transactions

Recent executive and insider activity

Vassily Kevin

Transaction: 03/18/2026

OTHER

Change

Price

Not reported

Filing

03/25/2026

Type

OTHER

General John Conrad

Transaction: 03/18/2026

OTHER

Change

Price

Not reported

Filing

03/19/2026

Type

OTHER

Yang Weiguang

Transaction: 03/18/2026

OTHER

Change

Price

Not reported

Filing

03/18/2026

Type

OTHER

Insider	Type	Price	Transaction	Filing
Vassily Kevin	OTHER	Not reported	03/18/2026	03/25/2026
General John Conrad	OTHER	Not reported	03/18/2026	03/19/2026
Yang Weiguang	OTHER	Not reported	03/18/2026	03/18/2026
Yang Weiguang	OTHER	Not reported	03/18/2026	03/18/2026
LI DAN	OTHER	Not reported	03/18/2026	03/18/2026
Xu Pei	OTHER	Not reported	03/18/2026	03/18/2026

About the Company

Zhongchao Inc.

Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People’s Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, including the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.

Source - link

Peers

GLMD HSCS ISPC NIVF OCEA TIVC UPC VTAK WOK XRTX

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

Zhongchao Inc. Announces $5.0 Million Registered Direct Offering

SHANGHAI, July 23, 2026 /PRNewswire/ -- Zhongchao Inc ("Zhongchao" or the "Company") (NASDAQ: ZCMD), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 4,545,455 of the Company's Class A Ordinary Shares, par value $0.744 per share (the "Shares") (or pre-funded warrants in lieu thereof) at a purchase price of $1.10 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $ 0.001 per share.

PRNewsWire

Zhongchao Inc. Announces 1-for-3 Share Consolidation

SHANGHAI, June 25, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-3 share consolidation of the Company's ordinary shares of US$0.248 par value each (the "Share Consolidation"). Beginning with the opening of trading on June 29, 2026, the Company's Class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol "ZCMD," but under a new CUSIP number of G9897X149.

PRNewsWire